Two Sigma Investments LP Purchases 110,758 Shares of Azenta, Inc. (NASDAQ:AZTA)

Two Sigma Investments LP raised its stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 178.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 172,795 shares of the company's stock after acquiring an additional 110,758 shares during the quarter. Two Sigma Investments LP owned approximately 0.38% of Azenta worth $8,640,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AZTA. Picton Mahoney Asset Management raised its holdings in shares of Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock valued at $35,000 after buying an additional 532 shares during the last quarter. Headlands Technologies LLC bought a new position in shares of Azenta in the fourth quarter valued at about $40,000. Covestor Ltd raised its holdings in shares of Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock valued at $102,000 after buying an additional 799 shares during the last quarter. KBC Group NV raised its holdings in shares of Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after buying an additional 698 shares during the last quarter. Finally, Quarry LP bought a new position in shares of Azenta in the fourth quarter valued at about $110,000. 99.08% of the stock is owned by institutional investors.

Azenta Stock Down 2.2%

AZTA stock traded down $0.62 during midday trading on Wednesday, reaching $27.10. The stock had a trading volume of 667,023 shares, compared to its average volume of 692,194. The firm has a market cap of $1.24 billion, a price-to-earnings ratio of -9.09 and a beta of 1.64. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The business has a fifty day simple moving average of $28.65 and a two-hundred day simple moving average of $40.72.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same period last year, the business earned $0.06 earnings per share. The business's revenue was up 5.1% on a year-over-year basis. On average, equities analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC lowered their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Finally, Evercore ISI lifted their price objective on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.